|
Sam Nickerson joined Tullis-Dickerson as an Associate in 2003 and was promoted to Vice President in 2006. His prior experience in the venture capital industry includes positions at S.R. One and ARCH Development Partners.
Mr. Nickerson began his career as a securities analyst at Bramwell Capital Management where he specialized in the pharmaceutical biotechnology and medical device industries. He later started an independent consulting practice in which he helped emerging medical technology companies secure private financing and strategic investment. Mr. Nickerson also held management positions in finance and marketing at Bioject Medical Technologies.
Mr. Nickerson received an MBA from The University of Chicago Graduate School of Business where he was a Neubauer Scholar. He also holds a BA in biochemistry and molecular biology from Reed College. | 